Luis Jorge Valdivia
Overview
Explore the profile of Luis Jorge Valdivia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbeta E, Barreiros C, Forin E, Guzzardella A, Motos A, Fernandez-Barat L, et al.
Ann Intensive Care
. 2025 Feb;
15(1):27.
PMID: 39998751
Background: The relative contribution of the different components of mechanical power to mortality is a subject of debate and has not been studied in COVID-19. The aim of this study...
2.
Ceccato A, Forne C, Bos L, Camprubi-Rimblas M, Areny-Balaguero A, Campana-Duel E, et al.
Crit Care
. 2024 Mar;
28(1):91.
PMID: 38515193
Background: Acute respiratory distress syndrome (ARDS) can be classified into sub-phenotypes according to different inflammatory/clinical status. Prognostic enrichment was achieved by grouping patients into hypoinflammatory or hyperinflammatory sub-phenotypes, even though...
3.
Galli F, Bindo F, Motos A, Fernandez-Barat L, Barbeta E, Gabarrus A, et al.
Intensive Care Med
. 2023 Jul;
49(8):934-945.
PMID: 37507573
Purpose: Although the prevalence of community-acquired respiratory bacterial coinfection upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported to be < 5%, almost three-quarters of patients...
4.
Bermejo-Martin J, Garcia-Mateo N, Motos A, Resino S, Tamayo L, Ryan Murua P, et al.
Lancet Microbe
. 2023 Apr;
4(6):e431-e441.
PMID: 37116517
Background: The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear. We aimed to evaluate associations between viral RNA load in plasma and host response, complications,...
5.
Gonzalez J, de Batlle J, Benitez I, Torres G, Santisteve S, Targa A, et al.
Arch Bronconeumol
. 2023 Jan;
59(4):205-215.
PMID: 36690515
Introduction: Critical COVID-19 survivors have a high risk of respiratory sequelae. Therefore, we aimed to identify key factors associated with altered lung function and CT scan abnormalities at a follow-up...
6.
Riera J, Barbeta E, Tormos A, Mellado-Artigas R, Ceccato A, Motos A, et al.
Eur Respir J
. 2022 Nov;
61(3).
PMID: 36396142
Background: The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with coronavirus disease 2019 (COVID-19)-associated respiratory failure. We...
7.
Torres A, Motos A, Cilloniz C, Ceccato A, Fernandez-Barat L, Gabarrus A, et al.
Intensive Care Med
. 2022 Jun;
48(7):850-864.
PMID: 35727348
Purpose: Although there is evidence supporting the benefits of corticosteroids in patients affected with severe coronavirus disease 2019 (COVID-19), there is little information related to their potential benefits or harm...
8.
Benitez I, de Batlle J, Torres G, Gonzalez J, de Gonzalo-Calvo D, Targa A, et al.
Lancet Reg Health Eur
. 2022 Jun;
18:100422.
PMID: 35655660
Background: The clinical heterogeneity of COVID-19 suggests the existence of different phenotypes with prognostic implications. We aimed to analyze comorbidity patterns in critically ill COVID-19 patients and assess their impact...
9.
Torres A, Motos A, Ceccato A, Bermejo-Martin J, de Gonzalo-Calvo D, Perez R, et al.
Arch Bronconeumol
. 2022 May;
58 Suppl 1:22-31.
PMID: 35491287
Introduction: The COVID-19 pandemic created tremendous challenges for health-care systems. Intensive care units (ICU) were hit with a large volume of patients requiring ICU admission, mechanical ventilation, and other organ...
10.
Bermejo-Martin J, Gonzalez-Rivera M, Almansa R, Micheloud D, Tedim A, Dominguez-Gil M, et al.
Crit Care
. 2020 Dec;
24(1):691.
PMID: 33317616
Background: COVID-19 can course with respiratory and extrapulmonary disease. SARS-CoV-2 RNA is detected in respiratory samples but also in blood, stool and urine. Severe COVID-19 is characterized by a dysregulated...